• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长 QT 综合征 1 型无义突变的通读可恢复功能,但改变了通道的生物物理特性。

Readthrough of long-QT syndrome type 1 nonsense mutations rescues function but alters the biophysical properties of the channel.

机构信息

William Harvey Heart Centre, Barts & The London School of Medicine & Dentistry, Charterhouse Square, London EC1M 6BQ, UK.

出版信息

Biochem J. 2012 May 1;443(3):635-42. doi: 10.1042/BJ20111912.

DOI:10.1042/BJ20111912
PMID:22309168
Abstract

The nonsense mutations R518X-KCNQ1 and Q530X-KCNQ1 cause LQT1 (long-QT syndrome type 1) and result in a complete loss of I(Ks) channel function. In the present study we attempted to rescue the function of these mutants, in HEK (human embryonic kidney)-293 cells, by promoting readthrough of their PTCs (premature termination codons) using the pharmacological agents G-418, gentamicin and PTC124. Gentamicin and G-418 acted to promote full-length channel protein expression from R518X at 100 μM and from Q530X at 1 mM. In contrast, PTC124 did not, at any dose tested, induce readthrough of either mutant. G-418 (1 mM) treatment also acted to significantly (P<0.05) increase current density and peak-tail current density, at +80 mV for R518X, but not Q530X, to 58±11% and 82±17% of the wild-type level respectively. However, the biophysical properties of the currents produced from R518X, while similar, were not identical with wild-type as the voltage-dependence of activation was significantly (P<0.05) shifted by +25 mV. Overall, these findings indicate that although functional rescue of LQT1 nonsense mutations is possible, it is dependent on the degree of readthrough achieved and the effect on channel function of the amino acid substituted for the PTC. Such considerations will determine the success of future therapies.

摘要

无义突变 R518X-KCNQ1 和 Q530X-KCNQ1 导致 LQT1(长 QT 综合征 1 型),并导致 I(Ks) 通道功能完全丧失。在本研究中,我们试图通过使用药物 G-418、庆大霉素和 PTC124 促进其 PTC(过早终止密码子)的通读,来挽救这些突变体在 HEK(人胚肾)-293 细胞中的功能。庆大霉素和 G-418 在 100μM 时可促进全长通道蛋白从 R518X 表达,在 1mM 时可促进全长通道蛋白从 Q530X 表达。相比之下,在测试的任何剂量下,PTC124 均不能诱导任一突变体的通读。G-418(1mM)处理还显著(P<0.05)增加了 R518X 在 +80 mV 时的电流密度和峰尾电流密度,分别达到野生型水平的 58±11%和 82±17%,但 Q530X 则不然。然而,来自 R518X 的电流的生物物理特性虽然相似,但与野生型并不完全相同,因为激活的电压依赖性显著(P<0.05)偏移了+25 mV。总体而言,这些发现表明,尽管可以实现 LQT1 无义突变的功能挽救,但这取决于实现的通读程度以及对 PTC 取代的氨基酸对通道功能的影响。这些考虑因素将决定未来治疗的成功。

相似文献

1
Readthrough of long-QT syndrome type 1 nonsense mutations rescues function but alters the biophysical properties of the channel.长 QT 综合征 1 型无义突变的通读可恢复功能,但改变了通道的生物物理特性。
Biochem J. 2012 May 1;443(3):635-42. doi: 10.1042/BJ20111912.
2
Calmodulin is essential for cardiac IKS channel gating and assembly: impaired function in long-QT mutations.钙调蛋白对于心脏IKS通道门控和组装至关重要:长QT突变中的功能受损。
Circ Res. 2006 Apr 28;98(8):1055-63. doi: 10.1161/01.RES.0000218979.40770.69. Epub 2006 Mar 23.
3
The rate-dependent biophysical properties of the LQT1 H258R mutant are counteracted by a dominant negative effect on channel trafficking.LQT1 H258R 突变体的速率依赖性生物物理特性被其对通道运输的显性负效应所抵消。
J Mol Cell Cardiol. 2010 Jun;48(6):1096-104. doi: 10.1016/j.yjmcc.2009.10.027. Epub 2009 Nov 11.
4
Comparison of read-through effects of aminoglycosides and PTC124 on rescuing nonsense mutations of HERG gene associated with long QT syndrome.比较氨基糖苷类药物和 PTC124 对挽救与长 QT 综合征相关的 HERG 基因无义突变的通读效果。
Int J Mol Med. 2014 Mar;33(3):729-35. doi: 10.3892/ijmm.2013.1601. Epub 2013 Dec 23.
5
A double-point mutation in the selectivity filter site of the KCNQ1 potassium channel results in a severe phenotype, LQT1, of long QT syndrome.KCNQ1钾通道选择性过滤器位点的双点突变导致长QT综合征的严重表型LQT1。
J Cardiovasc Electrophysiol. 2008 May;19(5):541-9. doi: 10.1111/j.1540-8167.2007.01076.x. Epub 2008 Feb 4.
6
Cellular mechanisms underlying the increased disease severity seen for patients with long QT syndrome caused by compound mutations in KCNQ1.KCNQ1复合突变导致的长QT综合征患者疾病严重程度增加的细胞机制。
Biochem J. 2014 Aug 15;462(1):133-42. doi: 10.1042/BJ20140425.
7
The G314S KCNQ1 mutation exerts a dominant-negative effect on expression of KCNQ1 channels in oocytes.G314S KCNQ1突变对卵母细胞中KCNQ1通道的表达产生显性负性效应。
Biochem Biophys Res Commun. 2009 May 29;383(2):206-9. doi: 10.1016/j.bbrc.2009.03.160. Epub 2009 Apr 5.
8
Biophysical characteristics of a new mutation on the KCNQ1 potassium channel (L251P) causing long QT syndrome.导致长QT综合征的KCNQ1钾通道新突变(L251P)的生物物理特性
Can J Physiol Pharmacol. 2003 Feb;81(2):129-34. doi: 10.1139/y02-162.
9
Stop-codon and C-terminal nonsense mutations are associated with a lower risk of cardiac events in patients with long QT syndrome type 1.在1型长QT综合征患者中,终止密码子和C末端无义突变与较低的心脏事件风险相关。
Heart Rhythm. 2016 Jan;13(1):122-31. doi: 10.1016/j.hrthm.2015.08.033. Epub 2015 Aug 28.
10
Congenital long QT syndrome caused by the F275S KCNQ1 mutation: mechanism of impaired channel function.由F275S KCNQ1突变引起的先天性长QT综合征:通道功能受损的机制。
Biochem Biophys Res Commun. 2009 Feb 27;380(1):127-31. doi: 10.1016/j.bbrc.2009.01.051. Epub 2009 Jan 22.

引用本文的文献

1
Therapeutic Opportunities in Overcoming Premature Termination Codons in Epidermolysis Bullosa via Translational Readthrough.通过翻译通读克服大疱性表皮松解症中过早终止密码子的治疗机会。
Cells. 2025 Aug 7;14(15):1215. doi: 10.3390/cells14151215.
2
Suppressor tRNA in gene therapy.抑制 tRNA 在基因治疗中的作用。
Sci China Life Sci. 2024 Oct;67(10):2120-2131. doi: 10.1007/s11427-024-2613-y. Epub 2024 Jun 24.
3
Pharmaceuticals Promoting Premature Termination Codon Readthrough: Progress in Development.促进过早终止密码子通读的药物:开发进展。
Biomolecules. 2023 Jun 14;13(6):988. doi: 10.3390/biom13060988.
4
Recoding of Nonsense Mutation as a Pharmacological Strategy.将无义突变重新编码作为一种药理学策略。
Biomedicines. 2023 Feb 22;11(3):659. doi: 10.3390/biomedicines11030659.
5
Membrane pools of phosphatidylinositol-4-phosphate regulate KCNQ1/KCNE1 membrane expression.膜池的磷脂酰肌醇-4-磷酸调节 KCNQ1/KCNE1 膜表达。
Commun Biol. 2021 Dec 14;4(1):1392. doi: 10.1038/s42003-021-02909-1.
6
Ataluren-Promising Therapeutic Premature Termination Codon Readthrough Frontrunner.阿他芦仑——有前景的治疗性提前终止密码子通读领先药物。
Pharmaceuticals (Basel). 2021 Aug 9;14(8):785. doi: 10.3390/ph14080785.
7
Nonsense suppression therapies in human genetic diseases.无义抑制疗法在人类遗传疾病中的应用。
Cell Mol Life Sci. 2021 May;78(10):4677-4701. doi: 10.1007/s00018-021-03809-7. Epub 2021 Mar 22.
8
Serum starvation enhances nonsense mutation readthrough.血清饥饿增强无义突变通读。
J Mol Med (Berl). 2019 Dec;97(12):1695-1710. doi: 10.1007/s00109-019-01847-0. Epub 2019 Nov 15.
9
Caffeine boosts Ataluren's readthrough activity.咖啡因可增强阿他芦醇的通读活性。
Heliyon. 2019 Jun 21;5(6):e01963. doi: 10.1016/j.heliyon.2019.e01963. eCollection 2019 Jun.
10
The effect of PTC124 on choroideremia fibroblasts and iPSC-derived RPE raises considerations for therapy.PTC124 对脉络膜视网膜变性成纤维细胞和 iPSC 衍生的 RPE 的作用引发了对治疗的考虑。
Sci Rep. 2018 May 29;8(1):8234. doi: 10.1038/s41598-018-26481-7.